BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12430178)

  • 21. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
    Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
    Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
    Hyder SM; Nawaz Z; Chiappetta C; Stancel GM
    Cancer Res; 2000 Jun; 60(12):3183-90. PubMed ID: 10866309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780.
    Hyder SM; Chiappetta C; Murthy L; Stancel GM
    Cancer Res; 1997 Jul; 57(13):2547-9. PubMed ID: 9205050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 17Beta-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-alpha and -beta.
    Gargett CE; Zaitseva M; Bucak K; Chu S; Fuller PJ; Rogers PA
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4341-9. PubMed ID: 12213896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture.
    Classen-Linke I; Alfer J; Krusche CA; Chwalisz K; Rath W; Beier HM
    Steroids; 2000; 65(10-11):763-71. PubMed ID: 11108887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
    McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
    Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
    Varma H; Conrad SE
    Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of reproductive hormones on ovarian epithelial tumors: II. Effect on angiogenic activity.
    Chen C; Petitclerc E; Zhou H; Brooks PC; Sun T; Yu MC; Zheng W; Dubeau L
    Cancer Biol Ther; 2002; 1(3):307-12. PubMed ID: 12432284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo.
    Guo P; Fang Q; Tao HQ; Schafer CA; Fenton BM; Ding I; Hu B; Cheng SY
    Cancer Res; 2003 Aug; 63(15):4684-91. PubMed ID: 12907650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.
    Fitzpatrick TE; Lash GE; Yanaihara A; Charnock-Jones DS; Macdonald-Goodfellow SK; Graham CH
    Exp Cell Res; 2003 Feb; 283(2):247-55. PubMed ID: 12581744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes.
    Brenneisen P; Blaudschun R; Gille J; Schneider L; Hinrichs R; Wlaschek M; Eming S; Scharffetter-Kochanek K
    Biochem J; 2003 Jan; 369(Pt 2):341-9. PubMed ID: 12358602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
    Liang Y; Besch-Williford C; Brekken RA; Hyder SM
    Cancer Res; 2007 Oct; 67(20):9929-36. PubMed ID: 17942925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
    Venditti M; Iwasiow B; Orr FW; Shiu RP
    Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
    Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
    Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.